Sonova beats expectations, lands USD 1.74bn revenue

Hearing aid manufacturer Sonova, which is headquartered in Switzerland, has seen the full benefits of the market recovery from Covid-19, and ends the first half of its financial year with revenue surpassing estimates. Nonetheless, the company has not upgraded its full-year guidance.

Photo: Arnd Wiegmann/Reuters/Ritzau Scanpix

The Swiss hearing aid manufacturer Sonova has announced its results from the skewed financial year 2021/2022, surpassing expectations in several key areas, it reports in its financial results from the period on Monday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs